A nterior cervical disc replacement (ACDR) has gained popularity as an alternative surgical option to anterior cervical discectomy and fusion (ACDF) for degenerative disc disease. [1] [2] [3] Studies of postoperative outcomes after ACDR have shown equitable or slightly improved clinical and radiological outcomes, when compared with ABBREVIATIONS: ACDF, anterior cervical disc fusion; ACDR, anterior cervical disc replacement; ASD, adjacent segment disease; CI, confidence interval; EQ-5D, EuroQol 5-Dimension; HO, heterotopic ossification; ICC, intraclass correlation coefficient; MCS, mental subscore; NDI, Neck Disability Index; PCS, physical subscore; SF-36, Short Form-36; VAS, visual analogue scale ACDF at 2 to 5 yr, [4] [5] [6] [7] [8] [9] together with superior cost-effectiveness. 10, 11 There are currently no studies of the efficacy of the NuNec™ (Pioneer R Surgical Technology, Marquette, Michigan) disc replacement, and additionally there is currently little information about whether outcomes are different for patients presenting with myelopathy, as opposed to radiculopathy. Reports have suggested that patients with myelopathy are generally older, have a more advanced condition, but show similar outcomes to those with radiculopathy. 12, 13 Cervical disc replacements aim to maintain movement at the symptomatic level, theoretically reducing the risk of adjacent segment disease (ASD), although a causative relationship between ACDF and ASD has not been formally proven. 2 Maintenance of movement has been demonstrated in over 80% of patients. 1, [14] [15] [16] In ACDR, the prosthesis generates biomechanical conditions closer to physiological parameters by maintaining motion at the affected level, whereas ACDF results in a reduced movement of the affected vertebrae, particularly after fusion of more than 1 level. 7 As a consequence, adjacent joint movement increases and adjacent disc pressure is greater after fusion. 7, 17, 18 Range of movement after ACDR is not always preserved, in part due to the development of heterotopic ossification (HO), 19 the development of which has been attributed to a number of factors, including natural progression of degeneration, 20 as well as iatrogenic causes, 19, 21, 22 which may be aggravated by reduced movement. 23 Disc replacements vary by material and design, which affect both motion preservation and wear and tear characteristics, and consequently the risk of HO development. 24 The NuNec™ disc replacement (Pioneer R Surgical Technology) has a semiconstrained ball and socket design with an integrated cam locking system (see Figure 1) . It is largely radiolucent on x-ray and magnetic resonance imaging. 25 The NuNec™ device is made from the polymer, polyether-etherketone, which differs from frequently used artificial discs such as the Bryan Disc (Medtronic Inc, Dublin, Ireland), Prestige (Medtronic Inc), PCM (NuVasive, San Diego, California), and ProDisc-C (DePuy Synthes, New Brunswick, New Jersey), which use metal alloys and ultrahigh molecular weight polyethylene; it has a hydroxyapatite covering to encourage bony ingrowth. The NuNec™ prosthesis has high radiation, thermal and aging resistance, good mechanical and biological performance, and generates smaller wear particles than some other discs, which may reduce the immune response that accelerates osteolysis. 26 The purpose of our study was to evaluate current data from a single site regarding the NuNec™ cervical disc replacement; we present 2-yr follow-up clinical and radiographic data including subgroup analysis for patients presenting with myelopathy and radiculopathy. 
METHODS
We prospectively collected data from a consecutive series of patients who presented to a single spinal surgery unit in London, UK with cervical radiculopathy or myelopathy and underwent ACDR, having given written consent, from 2009 to 2016. Patients were considered for cervical disc replacement if symptoms resulted from spondylotic disease; movement at the affected level was evident on dynamic flexion/extension x-rays; and they had undergone at least 6 wk of unsuccessful conservative management, which might include anti-inflammatory and analgesic medications, physical therapy, and nerve root or epidural injections. Contra-indications to ACDR included rheumatoid arthritis, osteoporosis, trauma, spinal tumour, infection, severe degenerative facet disease, ossification of the longitudinal ligament, and spine instability. Patients were undergoing routine clinical care and follow-up; as a result, ethical approval was not required.
Surgery was performed through a right-sided transverse skin-crease neck incision, using a standard anterior cervical retractor system. Subperiostial dissection of the longus colli muscles was performed to expose the disc space. An interbody disc distractor or vertebral body pin distractor was used. Discectomy was performed under the microscope with a high-speed drill, curettes, and Kerrison rongeurs, and the posterior longitudinal ligament was divided in all cases. After the endplates were decorticated to allow a close fit with the surface of the replacement, an appropriately sized disc replacement was inserted.
Prospective clinical outcome measures were collected preoperatively and by postal questionnaire at 3, 6, 12, and 24 mo, including visual analogue pain score for neck pain (VAS neck) and for arm pain (VAS arm), Neck Disability Index (NDI), Euroqol 5-dimension (EQ-5D) health status, and Short Form-36 (SF-36). Dynamic x-rays were taken as was deemed relevant for clinical follow-up, and were matched to the time points above. X-rays were assessed for the affected level range of movement by measuring the angle change between the superior and inferior endplates using lines drawn between bony points anteriorly and posteriorly that were reproducible on each pair of flexion/extension x-rays preoperatively, and tips of the radiolucent anterior aspect and the radiolucent marks at the rear of the implant postoperatively; a lordotic angle was taken as a positive value and kyphotic angle as negative ( Figure 2 ). Each level was measured 5 times by the same researcher and the average taken; reliability was assessed by using the intraclass correlation coefficient (ICC) and comparing residuals to mean movement change. Less than 2
• of measured movement was considered equal to fusion. 1, 15, 16 Lateral x-rays were also used to assess the presence of HO using the modified McAfee score, which ranges from 0 (no HO) to 4 (fusion), 27 grades 3 and 4 were taken as being clinically significant. 14 Results were explored using descriptive statistics, and hypothesis testing for differences between baseline and 2 yr for clinical and radiological data, using the paired t-test for continuous data, Mann-Whitney U-test for categorical data, and Spearman rank correlation coefficient to investigate relationships; significance was set at P = .05. All analysis was carried out using Stata 13 (StataCorp, College Station, Texas).
RESULTS
Of a total of 43 patients, 33 patients were followed-up for 2 yr. Thirteen were male (39%) and mean age was 48.3 (standard deviation, 8.7). Fourteen presented with radiculopathy, 12 with myelopathy, and 4 with a mixed picture. Of patients presenting with an element of myelopathy, 8 presented with soft disc hernia, 3 with osteophytes, and 4 with a mixed picture. Clinical details of 3 patients were unavailable (Table) .
A total of 44 NuNec™ disc replacements (Pioneer R Surgical Technology) were implanted. The majority of patients had 1-level operations (23, 70%), 9 had 2-level operations (27%), and 1 patient had a 3-level disc replacement operation (3%) according to clinical need and radiological findings. Five (11%) of the replacements were at C3/4, 8 (18%) at C4/5, 20 (45%) at C5/6, and 11 (25%) at C6/7.
Clinical Outcomes
All clinical outcomes had improved at the 2-yr follow-up, although significant variability was seen. Baseline and 2-yr followup data were available for 82%, 82%, 82%, 76%, and 85% of patients who had reached 2 yr postoperatively, for VAS neck, VAS arm, NDI, EQ-5D, and SF-36, respectively. There were no significant differences between changes seen for the radiculopathy or myelopathy groups for any of the clinical variables. The pattern of pain reduction is shown in Figures 3A and 3B . Broadly, the largest reduction is seen at 6 mo, with some return of pain over a longer time scale. At 2-yr follow-up, neck and arm pain were no longer significantly improved (P = .28; P = . The NDI demonstrated significant improvement at 2-yr follow-up (P < .01), with improvements seen by 6 mo and maintained at 2 yr ( Figure 3C) ; the mean reduction in score was -9.0 points (95% CI -14.2, -3.9) from a preoperative score of 33 EQ-5D also demonstrated a significant improved health status at follow-up (P < .01), some improvement was seen initially, peaking at 6 mo ( Figure 3D The physical subscore (PCS) of the SF-36 demonstrated a similar pattern to the other outcome measures, improving to 6 mo and then plateauing, while the mental subscore (MCS) demonstrated more variability after 6 mo ( Figures 3E and 3F) . At 2-yr follow-up, the improvement in PCS was significant (P = .02), which was not demonstrated in the MCS (P = .17). The average improvement in the PCS was 4.01 (95% CI 0.64, 7.38) from a baseline score of 35.06, the MCS improvement was 3.69 (95% CI -1.67, 9.06) from 46.62. In the subgroup analysis, the PCS remained significantly improved in the radiculopathy group but not the myelopathy group ( 
Radiological Outcomes
Radiological data were available for 17 (52%) patients at 1 yr and 12 (36%) at 2 yr, and for 23 (52%) operated levels at 1 yr and 15 (34%) at 2 yr postoperatively; flexion/extension X-rays were not considered clinically necessary in a number of cases, accounting for the low follow-up rate. Repeated measures of each x-ray resulted in residuals of less than 1
• across all measurements (0.99, 95% CI 0.92, 1.06), and individual ICC was greater than 0.76 at all time points, demonstrating good intrarater reliability.
Average movement between flexion and extension at the index level was 6.6
• preoperatively, and 4.0 • after 2 yr. Paired baseline 
FIGURE 5. Level of HO at the index level over time.
and follow-up data available from 13 levels demonstrated that the average angle change was -3.38
• (95% CI -6.00, -0.75), a statistically significant reduction (P = .02). Of operated levels, 72.7% demonstrated > 2
• of movement at follow-up; the progression can be seen in Figure 4 . Subgroup analysis did not demonstrate a significant reduction in the range of movement in the radiculopathy group, but was significant in the myelopathy group (mean [95% CI] -3.72
• [-10.14, 2.70], P = .18; -3.07 [-6 .03, -0.11] P = .04, respectively). There was no significant difference in the group changes, P = .76.
Clinically significant HO was seen at 5 levels (10.8%) preoperatively, all with level 3 HO. There was significantly more HO at follow-up (P < .01); 53.3% of levels demonstrated the clinically significant HO at 2 yr postoperatively, split evenly between levels 3 and 4 ( Figure 5 ). There was a significant relationship linking increased HO with reduced movement at the index level (r = -0.25, P < .01; Figure 6 ). There was no significant trend seen in either the radiculopathy or myelopathy subgroups (r = -0.23, P = .07; r = -0.15, P = .24, respectively).
Complications
A cohort of 30 patients was followed-up at the surgical hospital. Three patients (10.0%) had temporary dysphagia lasting less than 3 mo and none required further treatment. Two patients required foraminotomy at the index level for recurrence of symptoms, beyond 18 mo after the initial operation. No operations were carried out for ASD.
DISCUSSION
This report details the clinical and radiographical outcomes of a cohort of patients who underwent ACDR at a single spinal center, and is the first published clinical data for the NuNec™ disc replacement (Pioneer R Surgical Technology) including subgroup analysis of radiculopathy and myelopathy patients.
Clinical Benefits
Equitable or improved clinical outcomes have been demonstrated when comparing ACDR to fusion, using various other disc prostheses. [4] [5] [6] [7] [8] 28 The 2-yr postoperative scores from our patient group demonstrate clinical improvements in line with recent large-scale studies [4] [5] [6] [7] [8] [28] [29] [30] ; however, the percentage improvement is not as large. The results here are likely to be impacted by a lower operating threshold: preoperative VAS neck scores of 3.7 in this group demonstrate less impairment than seen in the study by Burkus et al, 4 in which patients demonstrated an average VAS of 6.8. This pattern is repeated across the other clinical outcome measures; similar reduced impairment is seen with VAS arm at 3.2 preoperatively compared to 5.91 in the study by Burkus et al, 4 Following the neck surgery for radiculopathy or myelopathy, short-term improvement in symptoms is frequently seen immediately after the surgery for patients with radiculopathy, and by 6 mo for patients with myelopathy, while ongoing degenerative disease processes or long-term surgical sequelae may impede further improvement. 20 Our results suggest that both groups of patients may clinically benefit from ACDR, and that there is a trend to these benefits being maintained for longer in patients with radiculopathy. This is in line with a large retrospective review of 5256 patients by Lukasiewicz et al, 13 who suggest that myelopathy is a more advanced condition, and that these patients may generally be older, less healthy, and have significantly greater risk of morbidity, although this was not found in smaller series.
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Movement Maintenance and Radiological Changes
The ability to maintain movement at the operated level is key to the theoretical benefit of ACDR when compared to ACDF 32 ; however, a recent systematic review did not identify a relationship between postoperative range of movement, or HO development and clinical outcomes 33 ; nevertheless, theoretically, the reduction in symptoms or need for future reoperations for ASD would represent a significant benefit.
In our patient group, maintained or improved movement is seen at the operated level up to the 6-mo follow-up; after this, there is a gradual but significant reduction in movement to a mean of 4.0
• at 2 yr (P = .02), demonstrated in Figure 4 ; at this stage, 72.7% of operated levels showed greater than 2
• of movement. Other studies have demonstrated movement in 82.9% to 88% of operated levels at 2 yr. 1, 14, 15 This may be a result of clinical bias from loss to follow-up, as the small cohort of patients with 24-mo dynamic x-rays are more likely to be those with greater impairment. Interestingly, the range of movement at baseline, 6.6
• , is lower when compared to other recent studies, which reported the range of movement of 7.5
• -12.8
• . 7, 14, 34 While this could be a difference in x-ray methodology and ability to elicit full range of movement for imaging, this difference may suggest that our cohort had greater mechanical impairment preoperatively that could influence the results; Ahn et al 35 suggested that fear of extremes of movement may limit neck range of movement on dynamic x-ray.
The development of clinically significant HO is reported in 0% to 33% of cases at 2 yr after surgery 1, 21, 36, 37 and has been implicated as a factor in the reduction of range of movement, 24 this is supported by our results (Figure 6 ). The objectivity of HO measurement has come under scrutiny; Choi et al 38 suggested that "the more you look, the more you see," and variability in measurement has also been linked to bias from conflicts of interest 2 ; many studies have formalized this by using the McAfee scale. 14 Yi et al 24 reported that there is a trend toward progression in HO, as measured by the McAfee scale, from a mean of 0.9 at baseline to 1.5 at 3 yr. Our patient group demonstrated greater HO at both baseline (mean 1.2) and follow-up (mean 2.6; Figure 5 ), with 10.8% of operated levels showing grade 3 or 4 HO at baseline, and 53.3% after 2 yr. This progression is statistically significant, and while this may be a result of the mechanical features of the NuNec™ (Pioneer R Surgical Technology) device or an iatrogenic response to bone drilling, it may also be due to clinical bias as noted above, ongoing disease processes, 20 or greater baseline impairment. Yi et al 24 reported that greater degrees of HO at follow-up are seen in patients with greater HO at baseline. Of note, in our myopathy cohort, 47% had an element of osteophyte formation that contributed to the surgical indication. Future research may identify if maintaining movement in this patient group, even if short term, is beneficial.
The development of HO and reduction of range of movement is only of interest if it is clinically significant. The clinical outcome measures in our patient group largely plateau after 6 mo, whereas this is the time point of reduction in range of movement and development of HO, suggesting the 2 are not closely related. The reoperation rate at 2 yr in this cohort, 6.7%, is marginally higher than seen in the literature for ACDR at 2 yr (2%-6%), 1, [4] [5] [6] [7] [8] [28] [29] [30] and may be a consequence of the small sample size, as this only related to 2 patients. Notably, this is not higher than the range of reoperation rates from recent large studies for ACDF (4%-9%) 1, [4] [5] [6] [7] [8] [28] [29] [30] and while there may be concerns about latefailure of devices, the small cohort of 21 patients in the study by Quan et al 23 , did not require any re-operations at 8 years. Of note in our cohort, there was no need for surgery of the adjacent segment, and no significant, long-term complications, which have been seen in 3% to 8% and 9% to 39% of patients in recent large studies of ACDR 1, [4] [5] [6] [7] [8] [28] [29] [30] .
Limitations
Small sample size and low follow-up rates, particularly for dynamic X-rays, may bias our results; however, as there is minimal data regarding the outcomes of NuNec TM disc replacement, we considered it helpful to report these results. Furthermore, this patient group was only followed-up to 2 yr, and there has been some concern of late device failures, as seen in large-joint arthroplasty, 3 although this has not been documented in ACDR studies to date.
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CONCLUSION
This is the first publication of clinical and radiological results following ACDR using the NuNec™ disc replacement (Pioneer R Surgical Technology). In this cohort, clinical outcomes have been comparable with other studies of ACDR and show a beneficial effect on the quality of life, and while the range of movement is decreased at the 2-yr follow-up and HO is common as with other disc replacements, reoperation rate was favorable. Furthermore, we have demonstrated no significant difference in outcome for patients presenting with radiculopathy or myelopathy, suggesting that ACDR is appropriate for both.
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